Episode 10: I’m shocked! The amazing potential and possibility of bioelectronic medicine with Doug Biehn of Cala Health
An estimated 10 million Americans live with debilitating tremors, but only about 40,000 are eligible or interested in the costly and invasive deep brain stimulation to treat it. Doug Biehn, chief commercial officer of Cala Health, talks with Justin about how his company is closing the treatment gap in this $20 billion market with accessible, patient-calibrated wearables. Doug explains what physicians are really looking for in new tech, how patient advocates are key to winning over providers and payors, and why healthcare startups need to be educators as well as innovators.
Justin and Doug also explore critical questions facing the medical device space: Is the “Medicare population” embracing self-serve chronic disease management? What’s driving doctors—and even drug companies—to invest in bioelectronics? And is the med device market destined to follow the consolidation patterns we see in biopharma?
To learn more about Definitive Healthcare, please visit us at definitivehc.com
